Ruxodox

INDICATIONS:

Used, often with other antineoplastics, in the treatment of Hodgkin’s disease, non-hodgkin’s lymphomas, acute leukemias, bone and soft-tissue sarcomas, neuroblastoma, Wilm’s tumour and malignant neoplasms of the bladder, breast, lungs, ovary, and stomach. It has also been used in other tumours.

Packaging: Single vial
Shelf Life: 24 mos
Origin: India
Regional MOQ: 92